SFM
TMO icon

Signet Financial Management’s Thermo Fisher Scientific TMO Stock Holding History

Signet Financial Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$268K Buy
545
+100
+22% +$54.3K 0.03% 266
2025
Q4 		$258K Buy
445
+8
+2% +$4.52K 0.03% 263
2025
Q3 		$212K Buy
+437
New +$203K 0.02% 287
2025
Q2 		– Sell
-436
Closed -$217K – 301
2025
Q1 		$217K Buy
436
+17
+4% +$9.21K 0.03% 270
2024
Q4 		$218K Buy
+419
New +$230K 0.03% 257
2024
Q2 		– Sell
-1,024
Closed -$595K – 275
2024
Q1 		$595K Sell
1,024
-34
-3% -$19.1K 0.08% 184
2023
Q4 		$562K Sell
1,058
-19
-2% -$9.2K 0.08% 184
2023
Q3 		$545K Sell
1,077
-5
-0.5% -$2.66K 0.09% 177
2023
Q2 		$565K Hold
1,082
– – 0.09% 184
2023
Q1 		$623K Sell
1,082
-2
-0.2% -$1.13K 0.11% 174
2022
Q4 		$597K Sell
1,084
-36
-3% -$19.1K 0.11% 175
2022
Q3 		$568K Buy
1,120
+2
+0.2% +$1.12K 0.11% 158
2022
Q2 		$607K Sell
1,118
-58
-5% -$31.9K 0.12% 153
2022
Q1 		$694K Buy
1,176
+4
+0.3% +$2.3K 0.12% 151
2021
Q4 		$782K Buy
1,172
+5
+0.4% +$3.12K 0.12% 143
2021
Q3 		$667K Buy
+1,167
New +$641K 0.12% 145
2021
Q2 		– Sell
-1,148
Closed -$524K – 222
2021
Q1 		$524K Buy
1,148
+10
+0.9% +$4.77K 0.1% 159
2020
Q4 		$530K Buy
1,138
+9
+0.8% +$4.22K 0.11% 158
2020
Q3 		$577K Buy
1,129
+228
+25% +$94.2K 0.13% 141
2020
Q2 		$370K Hold
901
– – 0.08% 176
2020
Q1 		$299K Sell
901
-36
-4% -$11.4K 0.07% 197
2019
Q4 		$304K Hold
937
– – 0.06% 207
2019
Q3 		$275K Buy
937
+37
+4% +$10.6K 0.05% 205
2019
Q2 		$258K Hold
900
– – 0.05% 209
2019
Q1 		$250K Hold
900
– – 0.05% 210
2018
Q4 		$201K Hold
900
– – 0.04% 217
2018
Q3 		$220K Sell
900
-1
-0.1% -$230 0.04% 217
2018
Q2 		$187K Buy
901
+900
+90,000% +$191K 0.03% 230
2018
Q1 		$0 Buy
+1
New +$210 ﹤0.01% 928

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Signet Financial Management's TMO Position: Q1 2026 in Review

Signet Financial Management increased its Thermo Fisher Scientific (TMO) stake by 22% in Q1 2026, buying an estimated $54.3K and bringing the position to 545 shares worth $268K. The position accounts for 0.03% of the portfolio, ranked #266.

Signet Financial Management first reported a position in TMO in Q1 2018 and has held it in 29 quarters since. The position peaked at $782K in Q4 2021. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Signet Financial Management held 545 shares of Thermo Fisher Scientific worth $268K as of Q1 2026.
  • Signet Financial Management bought 100 Thermo Fisher Scientific shares in Q1 2026, an estimated $54.3K.
  • Thermo Fisher Scientific made up 0.03% of Signet Financial Management's portfolio in Q1 2026, its #266 holding.
  • Signet Financial Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 29 quarters since.
  • Signet Financial Management's Thermo Fisher Scientific position peaked at $782K in Q4 2021.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.